Nuveen Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-200,943
| Closed | -$621K | – | 3269 |
|
|
2022
Q1 | $621K | Buy |
200,943
+1,413
| +0.7% | +$4.37K | ﹤0.01% | 2950 |
|
|
2021
Q4 | $1.23M | Sell |
199,530
-23,936
| -11% | -$147K | ﹤0.01% | 2782 |
|
|
2021
Q3 | $1.17M | Buy |
223,466
+32,365
| +17% | +$169K | ﹤0.01% | 2933 |
|
|
2021
Q2 | $1.21M | Sell |
191,101
-373,466
| -66% | -$2.36M | ﹤0.01% | 2941 |
|
|
2021
Q1 | $4.37M | Sell |
564,567
-45,829
| -8% | -$354K | ﹤0.01% | 2227 |
|
|
2020
Q4 | $4M | Sell |
610,396
-20,523
| -3% | -$134K | ﹤0.01% | 2184 |
|
|
2020
Q3 | $4.2M | Sell |
630,919
-92,882
| -13% | -$618K | ﹤0.01% | 2014 |
|
|
2020
Q2 | $6.03M | Buy |
723,801
+2,833
| +0.4% | +$23.6K | ﹤0.01% | 1797 |
|
|
2020
Q1 | $5.53M | Buy |
720,968
+18,660
| +3% | +$143K | ﹤0.01% | 1652 |
|
|
2019
Q4 | $5.84M | Sell |
702,308
-41,278
| -6% | -$343K | ﹤0.01% | 1903 |
|
|
2019
Q3 | $5.49M | Sell |
743,586
-814
| -0.1% | -$6.01K | ﹤0.01% | 1902 |
|
|
2019
Q2 | $8.35M | Buy |
+744,400
| New | +$8.35M | ﹤0.01% | 1717 |
|